Diagnostics Lab Meeting

In this month's Diagnostics Lab meeting, we will be hearing from two groups working to enable the flow of health information throughout numerous vendors, implementers, networks and governance frameworks. We’ll hear first from Mariann Yeager, CEO of The Sequoia Project which works closely with the Office of the National Coordinator for Health IT to identify and clear the barriers to interoperability at a national level. We will also hear from Stan Huff, Chief Medical Informatics Officer of Graphite Health, a non-profit, health-system member-governed organization aspiring to establish a trus

2022 Annual Public Meeting

2022 Annual Public Meeting

May 16, 2022
2:30-4 PM Eastern

Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share its activities in support of the U.S. Food and Drug Administration. This meeting is open to the public, but advanced registration is required.

Commissioner Robert M. Califf, MD, highlighted FDA's key priorities. 

Call for Nominations: Reagan-Udall Foundation for the FDA Seeks Nominations for the Innovations in Regulatory Science Awards

(April 4, 2022) The Reagan-Udall Foundation for the FDA (FDA Foundation) seeks nominations for its annual Innovations in Regulatory Science Awards. These awards recognize outstanding contributions made by individuals or organizations in the field of regulatory science.  

The Awards will be presented in three categories. Full nomination criteria and submission guidelines are available on the Foundation website.  

FDA’s Technology and Data Modernization in Action in 2022

In partnership with the Reagan-Udall Foundation, the FDA and the Friends of Cancer Research launched the Evidence Accelerator (EA) to advance the use of Real-World Data (RWD) to inform the COVID-19 response. In collaboration, ODT and the FDA’s Office of Food Policy and Response hosted the FDA New Era of Smarter Food Safety Low- or No-Cost Tech-Enabled Traceability Challenge.